Lipid oxidation products in ischemic porcine heart tissue

https://doi.org/10.1016/0009-3084(96)02557-1Get rights and content

Abstract

Infarcted porcine heart tissue and surrounding tissue were investigated for the content of plasmalogens and oxidatively derived corresponding α-hydroxyaldehydes as well as for products of lipid peroxidation, e.g. malondialdehyde, glyoxal, 2-hydroxyheptanal and oxygenated fatty acids. Oxidation products of unsaturated fatty acids and plasmalogens were accumulated in infarcted tissue compared to the surrounding one. Their amounts increased with time of ischemia. In addition leukotoxins (9,10-epoxy-12-octadecenoic acid and 12,13-epoxy-9-octadecenoic acid) as well as other epoxides of unsaturated fatty acids were identified. These compounds are absent in healthy heart tissue. Some of the monohydroxy fatty acids, found in comparable high yield, can not be derived from LPO processes. They are obviously generated from epoxides. Their distribution pattern indicates that they originate by an enzymic rather than by an autocatalytic process. We assume that the enzymes are activated by cell injury due to infarction. Linoleic acid seems to be an as equally well-suited substrate for enzymic attack as arachidonic acid.

References (54)

  • H.D Berkeley et al.

    Phytochemistry

    (1976)
  • H Esterbauer et al.

    Methods Enzymol.

    (1990)
  • L.K Dahle et al.

    Arch. Biochem. Biophys.

    (1962)
  • D.R Janero

    Free Radic. Biol. Med.

    (1990)
  • B Halliwell et al.

    FEBS Lett.

    (1981)
  • A Loidl-Stahlhofen et al.

    BBA

    (1994)
  • W.A Lehmann et al.

    Anal. Biochem.

    (1992)
  • H Hughes et al.

    Anal. Biochem.

    (1986)
  • D.W Thomas et al.

    Anal. Biochem.

    (1991)
  • R Felde et al.

    Chem. Phys. Lipids

    (1995)
  • H Kühn et al.

    J. Biol. Chem.

    (1990)
  • F.G.M Van Kuijk et al.

    Biochem. Biophys. Res. Commun.

    (1986)
  • A Loidl-Stahlhofen et al.

    Chem. Phys. Lipids

    (1995)
  • M Mizukami et al.

    Arzneim.-Forsch.

    (1984)
  • P.S Rao et al.
  • T Grune et al.

    Int. J. Tissue React.

    (1993)
  • E Schauenstein et al.

    Aldehydes in Biological Systems: Their Natural Occurence and Biological Activities

    (1987)
  • E Napetschnig et al.

    Chem.-Biol. Interact.

    (1988)
  • K Uchida et al.
  • A Mlakar et al.

    Chem. Phys. Lipids

    (1995)
  • W Jira et al.

    Chem. Phys. Lipids

    (1995)
  • T Hickethier
  • E.C Bligh et al.

    Can. J. Biochem. Physiol.

    (1959)
  • R.F Fletcher

    Lipids

    (1972)
  • W.W Christie et al.

    Lipids

    (1971)
  • H Kühn et al.

    Eur. J. Biochem.

    (1990)
  • M Herold et al.

    Chem. Phys. Lipids

    (1995)
  • Cited by (82)

    • Fatty acids and cardiac ischemia reperfusion injury

      2016, Handbook of Lipids in Human Function: Fatty Acids
    • Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice

      2013, Prostaglandins and Other Lipid Mediators
      Citation Excerpt :

      In addition, sEH null mice have been demonstrated to have significantly higher EpOME:DiHOME ratios and are protected against I/R injury suggesting that DiHOMEs can be detrimental to the heart [10]. In experimental models of myocardial ischemia, DiHOME levels rise from 1–3 μg/g of tissue to 4–22 μg/g of tissue [39]. DiHOMEs but not EpOME depress Na+ channels, K+ channels and trigger mitochondrial dysfunction [36,40,41].

    • Glycolate and 2-phosphoglycolate content of tissues measured by ion chromatography coupled to mass spectrometry

      2012, Analytical Biochemistry
      Citation Excerpt :

      A small amount of glyoxal is produced in cells from the peroxidation that occurs as a result of normal metabolism [3–5]. Some glycolate may also be produced by the reduction of glyoxylate by glyoxylate reductase (GRHPR), particularly in tissues that metabolize hydroxyproline such as the liver and kidney [1]. Our results with cultured hepatocytes have shown that there is a metabolic pathway from fructose to glycolate that is believed to arise from glycolaldehyde production, but in vivo studies with human subjects indicated that ingesting fructose in amounts up to 21% of the calories did not alter glycolate excretion, suggesting this pathway is minor [26].

    View all citing articles on Scopus
    View full text